Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
China · Delayed Price · Currency is CNY 7.40
+0.35 (4.96%)
Mar 26, 2026, 2:15 PM CST
SHE:000908 Revenue
Hunan Jingfeng Pharmaceutical had revenue of 88.47M CNY in the quarter ending September 30, 2025, a decrease of -3.97%. This brings the company's revenue in the last twelve months to 393.19M, down -1.15% year-over-year. In the year 2024, Hunan Jingfeng Pharmaceutical had annual revenue of 416.03M, down -36.67%.
Revenue (ttm)
393.19M
Revenue Growth
-1.15%
P/S Ratio
31.55
Revenue / Employee
718.80K
Employees
547
Market Cap
12.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 416.03M | -240.86M | -36.67% |
| Dec 31, 2023 | 656.89M | -183.76M | -21.86% |
| Jan 1, 2023 | 840.66M | 29.47M | 3.63% |
| Jan 1, 2022 | 811.18M | -66.74M | -7.60% |
| Dec 31, 2020 | 877.92M | -466.11M | -34.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 811.33M |
| Chongqing Lummy Pharmaceutical | 775.69M |